Loring Wolcott & Coolidge Fiduciary Advisors’s CVS Health CVS Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2026
Q2 | $98K | Hold |
947
| – | – | ﹤0.01% | 388 |
|
|
2026
Q1 | $75.1K | Sell |
947
-7,753
| -89% | -$597K | ﹤0.01% | 402 |
|
|
2025
Q4 | $626K | Hold |
8,700
| – | – | 0.01% | 216 |
|
|
2025
Q3 | $705K | Sell |
8,700
-273
| -3% | -$18.7K | 0.01% | 204 |
|
|
2025
Q2 | $619K | Hold |
8,973
| – | – | 0.01% | 193 |
|
|
2025
Q1 | $588K | Sell |
8,973
-750
| -8% | -$44.9K | 0.01% | 195 |
|
|
2024
Q4 | $546K | Sell |
9,723
-228
| -2% | -$12.8K | ﹤0.01% | 209 |
|
|
2024
Q3 | $558K | Sell |
9,951
-903
| -8% | -$52.7K | 0.01% | 205 |
|
|
2024
Q2 | $652K | Sell |
10,854
-1,957
| -15% | -$122K | 0.01% | 185 |
|
|
2024
Q1 | $892K | Sell |
12,811
-1,610
| -11% | -$123K | 0.01% | 154 |
|
|
2023
Q4 | $1.07M | Hold |
14,421
| – | – | 0.01% | 151 |
|
|
2023
Q3 | $1M | Sell |
14,421
-902
| -6% | -$63.9K | 0.01% | 150 |
|
|
2023
Q2 | $1.06M | Buy |
15,323
+5,250
| +52% | +$374K | 0.01% | 151 |
|
|
2023
Q1 | $749K | Sell |
10,073
-24
| -0.2% | -$2.01K | 0.01% | 168 |
|
|
2022
Q4 | $941K | Sell |
10,097
-16
| -0.2% | -$1.54K | 0.01% | 151 |
|
|
2022
Q3 | $964K | Sell |
10,113
-290
| -3% | -$28.7K | 0.01% | 148 |
|
|
2022
Q2 | $964K | Buy |
10,403
+124
| +1% | +$12.1K | 0.01% | 157 |
|
|
2022
Q1 | $1.04M | Sell |
10,279
-624
| -6% | -$65.6K | 0.01% | 159 |
|
|
2021
Q4 | $1.13M | Sell |
10,903
-2,314
| -18% | -$214K | 0.01% | 162 |
|
|
2021
Q3 | $1.12M | Sell |
13,217
-203
| -2% | -$17K | 0.01% | 158 |
|
|
2021
Q2 | $1.12M | Sell |
13,420
-12,718
| -49% | -$1.04M | 0.01% | 165 |
|
|
2021
Q1 | $1.97M | Buy |
26,138
+18
| +0.1% | +$1.31K | 0.02% | 119 |
|
|
2020
Q4 | $1.78M | Sell |
26,120
-2,430
| -9% | -$158K | 0.02% | 124 |
|
|
2020
Q3 | $1.67M | Sell |
28,550
-28,418
| -50% | -$1.77M | 0.02% | 117 |
|
|
2020
Q2 | $3.7M | Sell |
56,968
-53,453
| -48% | -$3.37M | 0.05% | 88 |
|
|
2020
Q1 | $6.55M | Sell |
110,421
-92,114
| -45% | -$6.15M | 0.11% | 67 |
|
|
2019
Q4 | $15M | Sell |
202,535
-43,256
| -18% | -$3.04M | 0.2% | 62 |
|
|
2019
Q3 | $15.5M | Sell |
245,791
-61,387
| -20% | -$3.64M | 0.23% | 58 |
|
|
2019
Q2 | $16.7M | Sell |
307,178
-12,531
| -4% | -$675K | 0.24% | 59 |
|
|
2019
Q1 | $17.2M | Sell |
319,709
-30,263
| -9% | -$1.87M | 0.26% | 59 |
|
|
2018
Q4 | $22.9M | Sell |
349,972
-2,130
| -0.6% | -$159K | 0.42% | 56 |
|
|
2018
Q3 | $27.7M | Sell |
352,102
-22,267
| -6% | -$1.59M | 0.44% | 52 |
|
|
2018
Q2 | $24.1M | Sell |
374,369
-39,643
| -10% | -$2.61M | 0.42% | 55 |
|
|
2018
Q1 | $25.8M | Sell |
414,012
-36,197
| -8% | -$2.6M | 0.47% | 50 |
|
|
2017
Q4 | $32.6M | Sell |
450,209
-11,893
| -3% | -$865K | 0.6% | 42 |
|
|
2017
Q3 | $37.6M | Sell |
462,102
-15,060
| -3% | -$1.19M | 0.73% | 41 |
|
|
2017
Q2 | $38.1M | Buy |
477,162
+2,750
| +0.6% | +$217K | 0.76% | 42 |
|
|
2017
Q1 | $37.2M | Sell |
474,412
-3,443
| -0.7% | -$275K | 0.78% | 42 |
|
|
2016
Q4 | $37.7M | Sell |
477,855
-9,289
| -2% | -$752K | 0.84% | 39 |
|
|
2016
Q3 | $43.4M | Buy |
487,144
+116,178
| +31% | +$11M | 0.99% | 34 |
|
|
2016
Q2 | $35.5M | Buy |
370,966
+35,692
| +11% | +$3.56M | 0.82% | 38 |
|
|
2016
Q1 | $34.8M | Buy |
335,274
+26,177
| +8% | +$2.55M | 0.82% | 38 |
|
|
2015
Q4 | $30.2M | Buy |
309,097
+54,373
| +21% | +$5.33M | 0.75% | 38 |
|
|
2015
Q3 | $26.7M | Hold |
254,724
| – | – | 0.68% | 40 |
|
|
2015
Q2 | $26.7M | Sell |
254,724
-755
| -0.3% | -$77.1K | 0.68% | 40 |
|
|
2015
Q1 | $26.4M | Sell |
255,479
-1,273
| -0.5% | -$129K | 0.67% | 41 |
|
|
2014
Q4 | $24.7M | Sell |
256,752
-1,770
| -0.7% | -$156K | 0.63% | 44 |
|
|
2014
Q3 | $20.6M | Buy |
258,522
+729
| +0.3% | +$57.5K | 0.56% | 47 |
|
|
2014
Q2 | $19.4M | Sell |
257,793
-9,713
| -4% | -$734K | 0.53% | 50 |
|
|
2014
Q1 | $20M | Sell |
267,506
-4,240
| -2% | -$299K | 0.55% | 49 |
|
|
2013
Q4 | $19.4M | Sell |
271,746
-6,869
| -2% | -$441K | 0.54% | 49 |
|
|
2013
Q3 | $15.8M | Sell |
278,615
-9,373
| -3% | -$559K | 0.48% | 53 |
|
|
2013
Q2 | $16.5M | Buy |
+287,988
| New | +$16.7M | 0.52% | 53 |
|
Other funds holding CVS
Loring Wolcott & Coolidge Fiduciary Advisors's CVS Position: Q2 2026 in Review
Loring Wolcott & Coolidge Fiduciary Advisors held its CVS Health (CVS) position steady in Q2 2026 at 947 shares worth $98K. The position accounts for ﹤0.01% of the portfolio, ranked #388.
Loring Wolcott & Coolidge Fiduciary Advisors first reported a position in CVS in Q2 2013 and has held it in 53 quarters since. The position peaked at $43.4M in Q3 2016. 1,271 funds tracked by Wall St. Rank hold CVS as of Q2 2026.
- Loring Wolcott & Coolidge Fiduciary Advisors held 947 shares of CVS Health worth $98K as of Q2 2026.
- Loring Wolcott & Coolidge Fiduciary Advisors left its CVS Health share count unchanged in Q2 2026.
- CVS Health made up ﹤0.01% of Loring Wolcott & Coolidge Fiduciary Advisors's portfolio in Q2 2026, its #388 holding.
- Loring Wolcott & Coolidge Fiduciary Advisors first reported a position in CVS Health in Q2 2013 and has held it in 53 quarters since.
- Loring Wolcott & Coolidge Fiduciary Advisors's CVS Health position peaked at $43.4M in Q3 2016.
- 1,271 funds tracked by Wall St. Rank held CVS Health as of Q2 2026.
Based on Loring Wolcott & Coolidge Fiduciary Advisors's 13F filing for Q2 2026, filed 30 Jul 2026.